Gemcitabine release kinetics determines the anticancer and immunomodulatory activity of HPMA copolymer nanomedicines.
- DOI
- 10.1016/j.jconrel.2026.115396
- Published
- 2026 Sep 23
- Container
- Journal of controlled release : official journal of the Controlled Release Society
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jconrel.2026.115396,
title = {Gemcitabine release kinetics determines the anticancer and immunomodulatory activity of HPMA copolymer nanomedicines.},
author = {Běhalová K and Pola R and Adamcová N and Ivančík M and Šírová M and Kilic IB and Procházková P and Kašpárek P and Bulková A and Lukáč P and Vannucci L and Říhová B and Etrych T and Kovář M},
year = {2026},
journal = {Journal of controlled release : official journal of the Controlled Release Society},
doi = {10.1016/j.jconrel.2026.115396},
url = {https://doi.org/10.1016/j.jconrel.2026.115396}
}RIS
TY - JOUR TI - Gemcitabine release kinetics determines the anticancer and immunomodulatory activity of HPMA copolymer nanomedicines. AU - Běhalová K AU - Pola R AU - Adamcová N AU - Ivančík M AU - Šírová M AU - Kilic IB AU - Procházková P AU - Kašpárek P AU - Bulková A AU - Lukáč P AU - Vannucci L AU - Říhová B AU - Etrych T AU - Kovář M PY - 2026 JO - Journal of controlled release : official journal of the Controlled Release Society DO - 10.1016/j.jconrel.2026.115396 UR - https://doi.org/10.1016/j.jconrel.2026.115396 ER -
APA
K, B., R, P., N, A., M, I., M, Š., IB, K., P, P., P, K., A, B., P, L., L, V., B, Ř., T, E., & M, K. (2026). Gemcitabine release kinetics determines the anticancer and immunomodulatory activity of HPMA copolymer nanomedicines.. Journal of controlled release : official journal of the Controlled Release Society. https://doi.org/10.1016/j.jconrel.2026.115396
Source records
- pubmed · retrieved 2026-09-25T04:17:20.908Z